Background: Methamphetamine use during pregnancy poses a number of risks to the pregnant woman, and the impact on children of in-utero exposure to methamphetamine has not yet been fully characterised. The aim of this study was to document pregnancy outcomes and infant developmental trajectories following antenatal methamphetamine use in an Australian setting.
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Background: Methamphetamine use during pregnancy poses a number of risks to the pregnant woman, and the impact on children of in-utero exposure to methamphetamine has not yet been fully characterised. The aim of this study was to document pregnancy outcomes and infant developmental trajectories following antenatal methamphetamine use in an Australian setting.
Methods: Methamphetamine-using women were recruited from a hospital-based specialist drug and alcohol antenatal service. The women provided information about drug use in each trimester of pregnancy. Complications of pregnancy and birth as well as basic neonatal data were recorded. Ages and Stages Questionnaires were completed by the infants' caregivers at 4 and 12 months, and developmental assessment was performed at 12 months using the Griffiths Mental Development Scales.
Results: 112 methamphetamine-using pregnant women were recruited. There were 110 live born infants. 65 of the infants returned for developmental follow-up at an average age of 13 months. The infants scored below-expected across all domains of the Griffiths assessment, with a mean General Quotient of 92.7. There was no specific pattern of delay. Statistical analysis found no effect of patterns of maternal methamphetamine use on Griffiths scores. The children who were removed from maternal custody at birth had lower scores than those that remained with their mothers. Ages and Stages Questionnaire results correlated poorly with Griffiths results.
Conclusions: Infants born to women using methamphetamine during pregnancy are at increased risk of developmental delay. Conclusions: This data supports the 'fetal programming' hypothesis, whereby exposure to utero-placental insufficiency can result in alterations predisposing to chronic respiratory disease. As greater respiratory morbidity occurred while postnatal variables were comparable, management of FGR cohorts needs to be individualized. Background: Australia's Health 2018 published by the AIHW identified a major data gap as 'the ability to identify populations of interest in health data.' This study demonstrates methodology to explore this specific gap by spatially describing risk factors and causes of stillbirth.
FETAL GROWTH RESTRICTION (FGR) AND RESPIRATORY MORBIDITY IN A VERY PRETERM BIRTH COHORT

GEOSPATIAL DISTRIBUTION OF RISK FACTORS AND CAUSES OF STILLBIRTH IN
Methods: A multi-centre prospective cohort study was conducted across 20 hospitals in Australia from 2014-2017. Stillbirth data was collected according to the national definition of 20 weeks gestation or 400 g and entered into a web-based platform at each site. Summary statistics for risk factors (ethnicity, socioeconomic status, overweight/obese, diabetes, and hypertension) and causes according to PSANZ recommendations were calculated. Using study data, a geodatabase was developed using the Australian Census GeoPackages shapefiles. Spatial patterns of risk factor and cause prevalence were determined using ESRI ArcMaps at the postcode level. Spatial autocorrelation was used to examine the spatial pattern of risk factor and cause rates.
Results: Excluding terminations, a total of 652 stillbirths were included. Unique spatial patterns were observed for risk factors and causes between metropolitan and remote settings. Leading causes of stillbirth were unexplained antepartum death (17%) and specific perinatal conditions (11%) and risk factors included overweight/obesity (30%) and low socioeconomic status (19%).
